Health Care·NASDAQ·All covered stocks

CytomX Therapeutics Inc. (NASDAQ: CTMX) Stock News & Analysis

CytomX Therapeutics Inc. (NASDAQ: CTMX) is a company in the Health Care sector, listed on the NASDAQ. This page collects all Alpha Stocks Insight coverage of CTMX: earnings reports, analyst actions, and company news, updated as new articles are published. 2 articles since April 30, 2026.

CTMX Coverage -- 2 Articles

Earnings Report·May 7, 2026

CytomX Therapeutics (NASDAQ: CTMX) Crushes Q1 Sales Estimate Despite Earnings Miss

CytomX's Q1 revenue more than doubled consensus, though per-share loss exceeded guidance in preliminary results.

3 min readRead article

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

CTMX Stock News & Analysis -- CytomX Therapeutics Inc. | Alpha Stocks Insight